Sangamo Therapeutics
SGMO
#10568
Rank
A$24.01 M
Marketcap
A$0.05796
Share price
-20.00%
Change (1 day)
-93.24%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.15 Billion, an increase over its 2023 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion19.29%
2024 -A$0.15 Billion-17.27%
2023 -A$0.18 Billion-40.88%
2022 -A$0.3 Billion9.79%
2021 -A$0.27 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.16 Billion36.33%
2018 -A$0.12 Billion36.89%
2017 -A$81.67 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$67.9 Million75.62%
2014 -A$38.67 Million0.13%
2013 -A$38.62 Million
2011 -A$51.91 Million43.66%
2010 -A$36.14 Million28.52%
2009 -A$28.12 Million-23.55%
2008 -A$36.78 Million2.45%
2007 -A$35.9 Million19.5%
2006 -A$30.04 Million50.78%
2005 -A$19.93 Million75%
2004 -A$11.39 Million-33.25%
2003 -A$17.06 Million-62.27%
2002 -A$45.21 Million102.82%
2001 -A$22.29 Million23.21%
2000 -A$18.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.64 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.16 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.35 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.67 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.19 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$19.05 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.26 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA